Maynard Um
-
-
-
-
-
-
-
Bicycle Therapeutics (BCYC) PT Lowered to $7 at RBC Capital
-
-
-
-
-
-
-
Bicycle Therapeutics names new CFO and CMO in leadership changes
-
-
-
-
-
-
-
RBC Capital Downgrades Bicycle Therapeutics (BCYC) to Sector Perform
-
-
-
-
-
-
-
Cantor Fitzgerald Reports Key Takeaways from Call With RadioMedia CEO
-
-
-
-
-
-
-
Citizens JMP Reiterates Market Outperform Rating on Bicycle Therapeutics (BCYC)
-
-
-
-
-
-
-
Morgan Stanley on Equalweight Rated Bicycle Therapeutics (BCYC): 'We view the ~30%+ down move as overdone'
-
-
-
-
-
-
-
B.Riley Reiterates Neutral Rating on Bicycle Therapeutics (BCYC)
-
431,647 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

